Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2024-03-22 Capital/Financing Update
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Rapport spécial du Conseil (art. 7-199) (27 fev 2024)_Web.pdf
Capital/Financing Update Classification · 92% confidence The document is titled "RAPPORT SPÉCIAL DU CONSEIL D'ADMINISTRATION AUX ACTIONNAIRES concernant l'utilisation du capital autorisé..." (Special Report of the Board of Directors to Shareholders concerning the use of authorized capital). It explicitly references Article 7:199 of the Belgian Code des sociétés et associations (CSA) and details the proposal to renew the board's powers to increase capital under the authorized capital framework, to be presented at an Extraordinary General Meeting (EGM). This document is a formal report prepared for shareholders regarding a specific corporate governance/financing matter (capital authorization renewal) that requires shareholder approval, rather than a general financial report (like 10-K or IR) or a simple announcement of a report (RPA/RNS). While it relates to capital structure, its primary function is to provide the required statutory report to shareholders concerning the proposed renewal of capital authorization powers, which aligns closely with documents related to shareholder meetings and corporate governance proposals. Given the options, it is a specific statutory report related to corporate actions requiring shareholder vote, which is not explicitly covered by the main financial reports. However, since it is a detailed report presented to shareholders regarding capital structure changes and governance proposals for an upcoming meeting, it is most closely related to the context of shareholder meetings and corporate governance. Since it is a detailed statutory report concerning capital structure and governance proposals for an EGM, and not a standard 10-K, IR, or a simple announcement, it fits best under a category related to corporate actions or governance. Given the options, 'Capital/Financing Update' (CAP) covers the subject matter (capital increase powers), but the format is a formal statutory report for an EGM. 'Governance Information' (CGR) is also plausible as it details board powers. However, the core subject is the authorization for capital changes. Since it is a formal report detailing the proposed changes to capital authorization powers for a shareholder vote, it is a specific type of corporate action document. If we consider the context of the EGM mentioned (April 25, 2024), this report is preparatory material for that meeting. It is not a DEF 14A (Remuneration) or a DVA (Voting Results). Given the focus on renewing the authority to issue capital, 'CAP' (Capital/Financing Update) is a strong candidate, although it is a statutory report rather than a simple press release update. Considering the detailed nature and statutory requirement under the CSA for this specific report related to capital authorization, it is a specialized financing/capital document. I will classify it as CAP due to the central theme of renewing capital authorization powers.
2024-03-22 French
Bijzonder verslag van de Raad (art. 7-199) (27 feb 2024)_Web.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR AAN DE AANDEELHOUDERS" (Special Report of the Board of Directors to the Shareholders) and explicitly refers to renewal of the authorization for the Board to increase capital within the framework of 'toegestane kapitaal' (authorized capital) according to Article 7:199 of the Belgian Companies and Associations Code (WVV). This document details the proposed changes to Article 6 of the company's articles of association regarding capital increases and the conditions under which the Board can use this authorization. This directly relates to the company's capital structure and financing powers, which aligns best with the 'Capital/Financing Update' category (CAP). It is not a standard Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA/RNS), but rather a detailed proposal concerning the company's capital authorization framework presented to shareholders for approval at an Extraordinary General Meeting.
2024-03-22 Dutch
Proxy General Meeting 25 April 2024 - ENG - Final.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is explicitly titled "PROXY FOR THE GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON 25 APRIL 2024". It contains detailed instructions on how to appoint a proxy holder, lists the agenda items for the General Meeting (including approval of annual accounts, remuneration reports, director appointments, and auditor renewal), and provides voting checkboxes (FOR/AGAINST/ABSTAIN) for each resolution. This content is characteristic of proxy materials distributed to shareholders ahead of an Annual General Meeting (AGM) to solicit their votes. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), although it is also closely related to AGM materials (AGM-R). Since it is the actual proxy form used to cast votes for the meeting, PSI is the most precise fit, as it solicits votes, whereas AGM-R often refers to the presentation materials used during the meeting itself. Given the structure, PSI is the primary classification.
2024-03-22 English
Proxy General Meeting 25 avril 2024 - FR - Final.pdf
AGM Information Classification · 99% confidence The document is titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 25 AVRIL 2024" (Proxy for the Shareholders' General Meeting of April 25, 2024). It is a form for shareholders to appoint a proxy to vote on various resolutions, including the approval of annual accounts, remuneration reports, director appointments, and long-term incentive plans. This material is directly related to soliciting votes for a general meeting and providing the necessary documentation/form for shareholder participation. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor is it the full Annual Report (10-K) or an Earnings Release (ER).
2024-03-22 French
Proxy General Meeting 25 April 2024 - NL - Final.pdf
AGM Information Classification · 99% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 25 APRIL 2024" (Proxy for the General Meeting of Shareholders of April 25, 2024). It contains instructions on how to appoint a proxy holder and outlines the agenda items for the meeting, which include voting on the annual accounts, remuneration report, director appointments, and incentive plans. This document is a proxy form or related material used to solicit shareholder votes for an upcoming general meeting. This aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). Although it mentions the Annual General Meeting (AGM-R), the document itself is the mechanism for voting/proxy submission, not the presentation materials (AGM-R) or the official voting results (DVA).
2024-03-22 Dutch
NBB_UCB SA_31.12.2023_EN Final.pdf
Audit Report / Information Classification · 98% confidence The document is a formal filing of 'Annual Accounts' for UCB SA, a Belgian company. It includes identification details, a list of directors, a declaration regarding audit assignments, and detailed balance sheet tables. This is a statutory financial filing required by the Belgian Companies and Associations Code. While it contains financial data, it is not a full Annual Report (10-K) which typically includes narrative business analysis, nor is it a standalone audit report. It fits the definition of a comprehensive financial report for a specific period, which in this context is classified as an Interim/Quarterly Report (IR) or, more accurately in this specific taxonomy, a formal financial filing of annual accounts. FY 2023
2024-03-22 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.